Biogen believes that some of its new drugs, Leqembi, Skyclarys and Zurzuvae, have the potential to revive long-term growth. Can Biogen achieve this goal?
Two bills aim to close gaps and ensure equitable access by requiring private health insurance coverage of FDA-approved Alzheimer’s treatments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback